Paratek Pharmaceuticals, Inc.

Paratek Pharmaceuticals, Inc.verified

PRTK

Price:

$2.23

Market Cap:

$127.83M

Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectrum antibiotic for the treatment of adult patients with community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections caused by susceptible pathogens; and SEYSARA, a tetracycline designed for the treatment of moderate to severe acne vulgaris. The company has license and collaboration agreements with Zai Lab (Shanghai) Co....[Read more]

Industry

Biotechnology

IPO Date

2009-02-03

Stock Exchange

NASDAQ

Ticker

PRTK

The PE Ratio as of June 2024 (TTM) for Paratek Pharmaceuticals, Inc. (PRTK) is -2.01

According to Paratek Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -2.01. This represents a change of -9.95% compared to the average of -2.23 of the last 4 quarters.

Paratek Pharmaceuticals, Inc. (PRTK) Historical PE Ratio (quarterly & annually)

How has PRTK PE Ratio performed in the past?

The mean historical PE Ratio of Paratek Pharmaceuticals, Inc. over the last ten years is -2.95. The current -2.01 PE Ratio has changed 6.70% with respect to the historical average. Over the past ten years (40 quarters), PRTK's PE Ratio was at its highest in in the June 2021 quarter at 8.27. The PE Ratio was at its lowest in in the December 2014 quarter at -39.66.

Quarterly (TTM)
Annual

Average

-2.95

Median

-2.59

Minimum

-5.47

Maximum

-1.03

Paratek Pharmaceuticals, Inc. (PRTK) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Paratek Pharmaceuticals, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 307.70%

Maximum Annual PE Ratio = -1.03

Minimum Annual Increase = -73.31%

Minimum Annual PE Ratio = -5.47

Quarterly (TTM)
Annual
YearPE RatioChange
2022-1.60-56.51%
2021-3.6854.68%
2020-2.38131.81%
2019-1.03-28.69%
2018-1.44-73.31%
2017-5.3992.97%
2016-2.79-36.76%
2015-4.42-19.17%
2014-5.47307.70%
2013-1.34-63.61%

Paratek Pharmaceuticals, Inc. (PRTK) Average PE Ratio

How has PRTK PE Ratio performed in the past?

The current PE Ratio of Paratek Pharmaceuticals, Inc. (PRTK) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-2.55

5-year avg

-2.02

10-year avg

-2.95

Paratek Pharmaceuticals, Inc. (PRTK) PE Ratio vs. Peers

How is PRTK’s PE Ratio compared to its peers?

Paratek Pharmaceuticals, Inc.’s PE Ratio is greater than Selecta Biosciences, Inc. (-3.39), greater than Corvus Pharmaceuticals, Inc. (-3.69), greater than Immutep Limited (-75.58), greater than Icosavax, Inc. (-8.27), less than Lyra Therapeutics, Inc. (0), less than Equillium, Inc. (-0.24), less than HOOKIPA Pharma Inc. (-2.01), less than LianBio (-1.86), less than Jasper Therapeutics, Inc. (-0.39), greater than Affimed N.V. (-4.84), less than Leap Therapeutics, Inc. (-0.92), less than Adaptimmune Therapeutics plc (-0.98), less than Aptose Biosciences Inc. (-1.30), less than null (-0.23),

Build a custom stock screener for Paratek Pharmaceuticals, Inc. (PRTK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Paratek Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Paratek Pharmaceuticals, Inc. (PRTK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Paratek Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Paratek Pharmaceuticals, Inc.'s PE Ratio?

How is the PE Ratio calculated for Paratek Pharmaceuticals, Inc. (PRTK)?

What is the highest PE Ratio for Paratek Pharmaceuticals, Inc. (PRTK)?

What is the 3-year average PE Ratio for Paratek Pharmaceuticals, Inc. (PRTK)?

What is the 5-year average PE Ratio for Paratek Pharmaceuticals, Inc. (PRTK)?

How does the current PE Ratio for Paratek Pharmaceuticals, Inc. (PRTK) compare to its historical average?